Lantern Pharma Inc

NASDAQ:LTRN   3:59:44 PM EDT
15.12
+0.03 (+0.20%)
Earnings Announcements

Lantern Pharma Reports Q1 2021 Financial Results

Published: 05/03/2021 21:00 GMT
Lantern Pharma Inc (LTRN) - Lantern Pharma Reports First Quarter 2021 Financial Results and Operational Highlights.
Q1 Loss per Share $0.24.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.27

More details on our Analysts Page.